Back to top

View the PFP Archive

ZACKS
Ominous Signs?

One could say that after 6 straight days in the plus column, stocks decided to rest on the 7th day. That is the optimistic view of Wednesday's activity.

Unfortunately it could also be said that the session bore a troubling resemblance to the painful showing for stocks earlier in April. I am referring to where the S&P barely moved at all while small cap, growth and tech names got SLAMMED!

This could be nothing more than a faint echo from the recent past that continues to fade away. Or perhaps it is a disturbing cycle of behavior that will keep haunting us into the future.

For now I choose to believe in the former path and staying focused on a shot above 1900 this spring. In fact, there are others thinking the same exact thing that this kind of pullback creates the perfect time to buy future momentum stocks. David Bartosiak outlines this timely approach in his latest investment ideas piece:

4 Steps to Mastering Momentum Stocks

Plus Other Featured Commentaries:

•  Value Stock Picks of the Week

•  Homebuilding Stocks: Has Spring Sprung?

Best,

Steve Reitmeister (aka Reity...pronounced "Righty")

Executive Vice President

Zacks Investment Research

Follow Us:  

Sponsor

5 Stocks to Ignite Next Week

Today, a brand-new Zacks' formula is applying a Best of Both Worlds approach to stock trading. It combines the proven fundamental power of the Zacks Rank with the "exactly when" timing of technical analysis.

There are 5 momentum stocks with extreme gain potential on our radar, but time is short to get aboard. Too many early investors could spoil the fun. Your opportunity ends Sunday, April 27.

Be first in line for these stocks.

Bull & Bear of the Day

Zacks Rank #1

Dangdang (DANG)

As the Alibaba mega IPO looms, it's time to look at the "little Amazon" of China.

 

Zacks Rank #5

Groupon (GRPN)

Group deals are fun and sound simple--except on Wall Street.


Stock Picking Strategies

Your Next Stock Should Be Making New Highs  ››

YUM's Earnings Mixed, China in Focus  ››

Roundtable Top Picks for the Week of Apr. 21st  ››


Funds Commentary

Zacks #1 Ranked Government Bond Mutual Funds  ››

Banking Sector Earnings Put These Financial ETFs in Focus  ››

Beef Up Your Portfolio with These Livestock ETFs  ››


Options Strategies

Winning With Option Volatility  ››


Video Reports

Pharma ETFs: A Better Healthcare Investment?

How have pharma ETFs held up during the biotech selloff?

What Matters to the Market?

Zacks experts provide an update on issues affecting the stock market.

Value Stock Picks of the Week- Apr 23, 2014

Value stock strategist, Tracey Ryniec, profiles SYNNEX Corporation (SNX) and Tata Motors Limited (TTM).

Earnings HQ

Today's Noteworthy Earnings Before the Bell:   ››  NVSVZMMMUPSAZN

Today's Noteworthy Earnings After the Bell:   ››  MSFTVAMZNLVSBIDU

Get the First Calendar Made for Traders.

Visit the Zacks Earnings Calendar

Recent Earnings Winners

Company Symbol Reported Surprise %Price Chg
TJT INC AXLE Apr 23 +0.01% +11.94%
SUPERVALU INC SVU Apr 23 +0.18% +11.54%
POPULAR INC BPOP Apr 23 +0.83% +7.57%
MANPOWERGROUP MAN Apr 23 +0.86% +7.10%
NATUS MEDICAL INC BABY Apr 23 +0.26% +6.93%

See All »

Best Earnings ESP Stocks  

Company Symbol Consensus
Est.
Most
Accurate Est.
Reports Zacks Rank ESP
ENTERGY CORP ETR 2.04 2.29 Apr 24 1 +12.25
NORTH AM PALLAD PAL -0.03 -0.02 May 1 1 +33.33
HELMERICH&PAYNE HP 1.47 1.48 Apr 24 1 +0.68
VERTEX PHARM VRTX -0.76 -0.66 May 1 1 +13.16
RENAISSANCERE RNR 2.73 2.99 Apr 29 1 +9.52
Don't trade these stocks until you have read the Zacks ESP Guide

Sponsor

Start Every Day Ahead of Wall Street

Before you make a trade, get today's market news from Zacks' latest Ahead of Wall Street article. With timely information from Zacks analysts, each daily article features a preview of where the market is headed. Plus, Bull and Bear stocks of the day, Zacks #1s on the move, stock research reports, earnings and economic news, and a top-headline analyst blog. All of it in one easy-to-follow place to give you the edge.

Get the latest news>>


Manage Your Newsletter Subscriptions

Update Preferences         Update Your Profile         Unsubscribe All         Feedback         Send to a Friend
 

This free resource is being sent by Zacks.com to our subscribers. We look for investment resources and inform you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable.

All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, brokerage, market making or asset management activities of any securities. Visit www.zacks.com/performance for information about the performance numbers displayed in this press release.

Zacks Emails

If you would prefer to not receive future profit-producing emails from Zacks.com the primary purpose of which is the commercial advertisement or promotion of a commercial product or service, then please click here and confirm your request. If you have trouble with the unsubscribe link, please email support@zacks.com.

Zacks Investment Research, Inc.
10 S. Riverside Plaza, Suite 1600
Chicago, IL 60606

Please login to Zacks.com or register to post a comment.